How to use the speech recognition tool?
Efficacy & Safety Study of Bilateral Intravitreal Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year (REFLECT).
Status of the trial: Active, Not recruiting
Orphan Drug Recognition: Yes
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators